Literature DB >> 20960031

Ligand-guided optimization of CXCR4 homology models for virtual screening using a multiple chemotype approach.

Marco A C Neves1, Sérgio Simões, M Luisa Sá e Melo.   

Abstract

CXCR4 is a G-protein coupled receptor for CXCL12 that plays an important role in human immunodeficiency virus infection, cancer growth and metastasization, immune cell trafficking and WHIM syndrome. In the absence of an X-ray crystal structure, theoretical modeling of the CXCR4 receptor remains an important tool for structure-function analysis and to guide the discovery of new antagonists with potential clinical use. In this study, the combination of experimental data and molecular modeling approaches allowed the development of optimized ligand-receptor models useful for elucidation of the molecular determinants of small molecule binding and functional antagonism. The ligand-guided homology modeling approach used in this study explicitly re-shaped the CXCR4 binding pocket in order to improve discrimination between known CXCR4 antagonists and random decoys. Refinement based on multiple test-sets with small compounds from single chemotypes provided the best early enrichment performance. These results provide an important tool for structure-based drug design and virtual ligand screening of new CXCR4 antagonists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20960031     DOI: 10.1007/s10822-010-9393-x

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  53 in total

1.  Crystal structure of rhodopsin: A G protein-coupled receptor.

Authors:  K Palczewski; T Kumasaka; T Hori; C A Behnke; H Motoshima; B A Fox; I Le Trong; D C Teller; T Okada; R E Stenkamp; M Yamamoto; M Miyano
Journal:  Science       Date:  2000-08-04       Impact factor: 47.728

2.  Virtual screening workflow development guided by the "receiver operating characteristic" curve approach. Application to high-throughput docking on metabotropic glutamate receptor subtype 4.

Authors:  Nicolas Triballeau; Francine Acher; Isabelle Brabet; Jean-Philippe Pin; Hugues-Olivier Bertrand
Journal:  J Med Chem       Date:  2005-04-07       Impact factor: 7.446

3.  Orally bioavailable isothioureas block function of the chemokine receptor CXCR4 in vitro and in vivo.

Authors:  Gebhard Thoma; Markus B Streiff; Jiri Kovarik; Fraser Glickman; Trixie Wagner; Christian Beerli; Hans-Günter Zerwes
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

Review 4.  Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1).

Authors:  B J Doranz; J F Berson; J Rucker; R W Doms
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

Review 5.  Chemokines and leukocyte traffic.

Authors:  M Baggiolini
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

6.  Do aligned sequences share the same fold?

Authors:  R A Abagyan; S Batalov
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

7.  The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques.

Authors:  S Abi-Younes; A Sauty; F Mach; G K Sukhova; P Libby; A D Luster
Journal:  Circ Res       Date:  2000-02-04       Impact factor: 17.367

Review 8.  CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.

Authors:  J A Burger; A Peled
Journal:  Leukemia       Date:  2008-11-06       Impact factor: 11.528

9.  Amine substituted N-(1H-benzimidazol-2ylmethyl)-5,6,7,8-tetrahydro-8-quinolinamines as CXCR4 antagonists with potent activity against HIV-1.

Authors:  Kristjan S Gudmundsson; Paul R Sebahar; Leah D'Aurora Richardson; John F Miller; Elizabeth M Turner; John G Catalano; Andrew Spaltenstein; Wendell Lawrence; Michael Thomson; Stephen Jenkinson
Journal:  Bioorg Med Chem Lett       Date:  2009-07-10       Impact factor: 2.823

10.  Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.

Authors:  Claudio N Cavasotto; Andrew J W Orry; Nicholas J Murgolo; Michael F Czarniecki; Sue Ann Kocsi; Brian E Hawes; Kim A O'Neill; Heather Hine; Marybeth S Burton; Johannes H Voigt; Ruben A Abagyan; Marvin L Bayne; Frederick J Monsma
Journal:  J Med Chem       Date:  2008-01-17       Impact factor: 7.446

View more
  10 in total

Review 1.  From laptop to benchtop to bedside: structure-based drug design on protein targets.

Authors:  Lu Chen; John K Morrow; Hoang T Tran; Sharangdhar S Phatak; Lei Du-Cuny; Shuxing Zhang
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

2.  Anti-HIV small-molecule binding in the peptide subpocket of the CXCR4:CVX15 crystal structure.

Authors:  Bryan D Cox; Anthony R Prosser; Brooke M Katzman; Ana A Alcaraz; Dennis C Liotta; Lawrence J Wilson; James P Snyder
Journal:  Chembiochem       Date:  2014-07-02       Impact factor: 3.164

3.  Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis.

Authors:  Jie Xia; Terry-Elinor Reid; Song Wu; Liangren Zhang; Xiang Simon Wang
Journal:  J Chem Inf Model       Date:  2018-05-08       Impact factor: 4.956

4.  Docking and scoring with ICM: the benchmarking results and strategies for improvement.

Authors:  Marco A C Neves; Maxim Totrov; Ruben Abagyan
Journal:  J Comput Aided Mol Des       Date:  2012-05-09       Impact factor: 3.686

5.  ALiBERO: evolving a team of complementary pocket conformations rather than a single leader.

Authors:  Manuel Rueda; Max Totrov; Ruben Abagyan
Journal:  J Chem Inf Model       Date:  2012-09-17       Impact factor: 4.956

6.  Drug design for ever, from hype to hope.

Authors:  G Seddon; V Lounnas; R McGuire; T van den Bergh; R P Bywater; L Oliveira; G Vriend
Journal:  J Comput Aided Mol Des       Date:  2012-01-18       Impact factor: 3.686

7.  Discovery and computer aided potency optimization of a novel class of small molecule CXCR4 antagonists.

Authors:  Victoria Vinader; Djevdet S Ahmet; Mohaned S Ahmed; Laurence H Patterson; Kamyar Afarinkia
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

8.  An Agonist of the CXCR4 Receptor Strongly Promotes Regeneration of Degenerated Motor Axon Terminals.

Authors:  Samuele Negro; Giulia Zanetti; Andrea Mattarei; Alice Valentini; Aram Megighian; Giulia Tombesi; Alessandro Zugno; Valentina Dianin; Marco Pirazzini; Silvia Fillo; Florigio Lista; Michela Rigoni; Cesare Montecucco
Journal:  Cells       Date:  2019-09-30       Impact factor: 6.600

9.  Discovery and characterization of novel small-molecule CXCR4 receptor agonists and antagonists.

Authors:  Rama K Mishra; Andrew K Shum; Leonidas C Platanias; Richard J Miller; Gary E Schiltz
Journal:  Sci Rep       Date:  2016-07-26       Impact factor: 4.379

10.  Discovery of HIV entry inhibitors via a hybrid CXCR4 and CCR5 receptor pharmacophore-based virtual screening approach.

Authors:  Muhammad Usman Mirza; Atefeh Saadabadi; Michiel Vanmeert; Outi M H Salo-Ahen; Iskandar Abdullah; Sandra Claes; Steven De Jonghe; Dominique Schols; Sarfraz Ahmad; Matheus Froeyen
Journal:  Eur J Pharm Sci       Date:  2020-09-02       Impact factor: 4.384

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.